쿼드메디슨

464490· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩4,515-0.88%

2026-09-18

Financials

Valuation Metrics

쿼드메디슨's Market Cap is ₩518B. At end of 2025 it was ₩1790B. Ranked #1752 of 2,421 in KR market (top 72%), #1065 of 1,640 on KOSDAQ (top 65%), #185 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 80%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	51.84B KRW	KR#1,752/2,421 Sec#185/231
Revenue	7.14B KRW	KR#2,315/2,421 Sec#184/231
Net Income	-10.11B KRW	KR—/2,421 Sec—/231
Total Assets	48.75B KRW	KR#2,219/2,421 Sec#203/231
Net Assets	24.55B KRW	KR#2,234/2,421 Sec#207/231
Value
P/B	2.11x	KR#1,967/2,421 Sec#147/231
P/S	7.26x	KR#2,223/2,421 Sec#154/231
FCF Yield	-13.00%	KR—/2,421 Sec—/231
Profitability
ROE	-41.18%	KR#2,247/2,421 Sec#191/231
ROA	-20.74%	KR#2,249/2,421 Sec#178/231
Op. Margin	-137.93%	KR#2,321/2,421 Sec#180/231
Revenue Growth	14.99%	KR#689/2,421 Sec#64/231
Financial Health
Debt Ratio	98.59%	KR#1,550/2,421 Sec#177/231
Total Debt	7.80B KRW	KR#1,695/2,421 Sec#155/231
FCF	-6.74B KRW	KR#1,580/2,421 Sec#127/231
Cash	8.16B KRW	KR#1,803/2,421 Sec#160/231
Current Ratio	1.58x	KR#1,128/2,421 Sec#122/231
Performance
1M Return	-16.39%	KR#2,269/2,421 Sec#198/231
From 52W High	-83.37%	KR#2,372/2,421 Sec#225/231
1Y MDD	-81.61%	KR#2,324/2,421 Sec#218/231
Trading
Volume	18,019 shares	KR#1,636/2,421 Sec#160/231
Trading Value	81.9M KRW	KR#1,646/2,421 Sec#165/231
Foreign Own.	4.22%	KR#998/2,421 Sec#90/231
Per Share
EPS	-880 KRW	KR—/2,421 Sec—/231
BPS	2,138 KRW	KR#2,036/2,421 Sec#167/231